Published in Dis Manag on August 01, 2005
Proxy assessment of health-related quality of life in african american and white respondents with prostate cancer: perspective matters. Med Care (2009) 0.83
Responses and relationship dynamics of men and their spouses during active surveillance for prostate cancer: health literacy as an inquiry framework. BMC Public Health (2015) 0.77
Evolution of a CDC Public Health Research Agenda for Low-Risk Prostate Cancer. Am J Prev Med (2015) 0.75
Radical prostatectomy versus observation for localized prostate cancer. N Engl J Med (2012) 24.06
The sequence and de novo assembly of the giant panda genome. Nature (2009) 15.76
2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline. J Clin Oncol (2006) 11.26
The genome of the cucumber, Cucumis sativus L. Nat Genet (2009) 8.19
Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy. J Natl Cancer Inst (2007) 4.97
Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology. J Clin Oncol (2002) 4.69
High rates of adverse drug events in a highly computerized hospital. Arch Intern Med (2005) 4.68
Low literacy impairs comprehension of prescription drug warning labels. J Gen Intern Med (2006) 4.01
Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2006 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol (2007) 3.91
Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update. J Clin Oncol (2007) 3.85
The association of health literacy with cervical cancer prevention knowledge and health behaviors in a multiethnic cohort of women. Am J Obstet Gynecol (2002) 3.63
Pure red-cell aplasia and epoetin therapy. N Engl J Med (2004) 3.49
Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project. J Am Coll Cardiol (2005) 3.38
Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a Review from the Research on Adverse Drug Events and Reports (RADAR) Project. Lancet Oncol (2009) 3.26
Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patients. J Natl Cancer Inst (2006) 3.23
Treatment success in cancer: new cancer treatment successes identified in phase 3 randomized controlled trials conducted by the National Cancer Institute-sponsored cooperative oncology groups, 1955 to 2006. Arch Intern Med (2008) 3.07
Small bowel cancer in the United States: changes in epidemiology, treatment, and survival over the last 20 years. Ann Surg (2009) 3.07
Systematic review and meta-analysis of monotherapy compared with combined androgen blockade for patients with advanced prostate carcinoma. Cancer (2002) 3.05
Social stigma concerns and HIV medication adherence. AIDS Patient Care STDS (2006) 3.02
Haematological malignancies developing in previously healthy individuals who received haematopoietic growth factors: report from the Research on Adverse Drug Events and Reports (RADAR) project. Br J Haematol (2006) 2.92
Factors associated with satisfaction with prostate cancer care: results from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE). BJU Int (2012) 2.88
Unintended consequences of health information technology: evidence from veterans affairs colorectal cancer oncology watch intervention. J Clin Oncol (2012) 2.67
The epidemiology of pain during the last 2 years of life. Ann Intern Med (2010) 2.62
Outcomes and complications associated with off-label and untested use of drug-eluting stents. JAMA (2007) 2.43
Advance care planning beyond advance directives: perspectives from patients and surrogates. J Pain Symptom Manage (2012) 2.41
Estimating the cost of cancer: results on the basis of claims data analyses for cancer patients diagnosed with seven types of cancer during 1999 to 2000. J Clin Oncol (2004) 2.33
The financial burden of cancer: estimates from a study of insured women with breast cancer. J Support Oncol (2004) 2.30
Bisphosphonates and nonhealing femoral fractures: analysis of the FDA Adverse Event Reporting System (FAERS) and international safety efforts: a systematic review from the Research on Adverse Drug Events And Reports (RADAR) project. J Bone Joint Surg Am (2013) 2.29
Colorectal cancer screening knowledge, attitudes, and beliefs among veterans: does literacy make a difference? J Clin Oncol (2004) 2.27
Reassessments of ESAs for cancer treatment in the US and Europe. Oncology (Williston Park) (2010) 2.22
Literacy, self-efficacy, and HIV medication adherence. Patient Educ Couns (2006) 2.18
Accelerated approval of cancer drugs: improved access to therapeutic breakthroughs or early release of unsafe and ineffective drugs? J Clin Oncol (2009) 2.16
American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer. J Clin Oncol (2010) 2.16
Health care provider-directed intervention to increase colorectal cancer screening among veterans: results of a randomized controlled trial. J Clin Oncol (2005) 2.10
Visual hallucinations in an elderly woman: a presentation of Charles Bonnet syndrome? J Am Geriatr Soc (2006) 2.10
The Research on Adverse Drug Events and Reports (RADAR) project. JAMA (2005) 2.08
Reduced penile size and treatment regret in men with recurrent prostate cancer after surgery, radiotherapy plus androgen deprivation, or radiotherapy alone. Urology (2013) 2.04
Development and validation of a short-form, rapid estimate of adult literacy in medicine. Med Care (2007) 2.04
Origin of morphotropic phase boundaries in ferroelectrics. Nature (2008) 1.94
The relationship between anxiety and time to treatment for patients with prostate cancer on surveillance. J Urol (2007) 1.91
Costs and cost-effectiveness of a low-intensity patient-directed intervention to promote colorectal cancer screening. J Clin Oncol (2007) 1.91
Clopidogrel-associated TTP: an update of pharmacovigilance efforts conducted by independent researchers, pharmaceutical suppliers, and the Food and Drug Administration. Stroke (2004) 1.78
Progressive multifocal leukoencephalopathy associated with brentuximab vedotin therapy: a report of 5 cases from the Southern Network on Adverse Reactions (SONAR) project. Cancer (2014) 1.76
Epoetin-associated pure red cell aplasia: past, present, and future considerations. Transfusion (2008) 1.73
ACCP: economic evaluations of clinical pharmacy services: 2001-2005. Pharmacotherapy (2009) 1.66
NCCN clinical practice guidelines in oncology: palliative care. J Natl Compr Canc Netw (2009) 1.66
A tale of two citizens: a State Attorney General and a hematologist facilitate translation of research into US Food and Drug Administration actions--a SONAR report. J Oncol Pract (2012) 1.63
Thalidomide- and lenalidomide-associated thromboembolism among patients with cancer. JAMA (2006) 1.59
Prioritizing future research on off-label prescribing: results of a quantitative evaluation. Pharmacotherapy (2008) 1.58
Literacy, race, and PSA level among low-income men newly diagnosed with prostate cancer. Urology (2006) 1.57
The incident user design in comparative effectiveness research. Pharmacoepidemiol Drug Saf (2012) 1.56
Post-cardiac catheterization access site complications and low-molecular -weight heparin following cardiac catheterization. J Invasive Cardiol (2003) 1.55
Health insurance coverage and the risk of decline in overall health and death among the near elderly, 1992-2002. Med Care (2006) 1.54
Legal, financial, and public health consequences of HIV contamination of blood and blood products in the 1980s and 1990s. Ann Intern Med (2002) 1.54
A clinical framework for improving the advance care planning process: start with patients' self-identified barriers. J Am Geriatr Soc (2009) 1.54
Finishing the picture: problems with public reporting of clinical trials. J Clin Oncol (2013) 1.52
Dissemination of information on potentially fatal adverse drug reactions for cancer drugs from 2000 to 2002: first results from the research on adverse drug events and reports project. J Clin Oncol (2003) 1.50
Czech health two decades on from the Velvet Revolution. Lancet (2009) 1.49
Guidelines for acute decompensated heart failure treatment. Ann Pharmacother (2004) 1.46
Measuring the health-related quality of life (HRQoL) of young children in resource-limited settings: a review of existing measures. Qual Life Res (2012) 1.45
Pneumonitis associated with nonsteroidal antiandrogens: presumptive evidence of a class effect. Ann Intern Med (2002) 1.45
American Society of Clinical Oncology recommendations for the initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer. J Clin Oncol (2004) 1.44
Association between hospital size and pharmacy department productivity. Am J Health Syst Pharm (2007) 1.43
Colorectal cancer screening among African-American and white male veterans. Am J Prev Med (2005) 1.39
Projecting future drug expenditures--2012. Am J Health Syst Pharm (2012) 1.37
Gemtuzumab ozogamicin-associated sinusoidal obstructive syndrome (SOS): an overview from the research on adverse drug events and reports (RADAR) project. Leuk Res (2006) 1.36
Evaluation of serious adverse drug reactions: a proactive pharmacovigilance program (RADAR) vs safety activities conducted by the Food and Drug Administration and pharmaceutical manufacturers. Arch Intern Med (2007) 1.34
Patient preferences in prostate cancer: a clinician's guide to understanding health utilities. Clin Prostate Cancer (2005) 1.33
The impact of reported direct and indirect killing on mental health symptoms in Iraq war veterans. J Trauma Stress (2010) 1.33
Proxy evaluation of health-related quality of life: a conceptual framework for understanding multiple proxy perspectives. Med Care (2005) 1.33
Hospitalizations for acute exacerbations of chronic obstructive pulmonary disease: how you count matters. COPD (2010) 1.29
Multiple domains of ADAMTS13 are targeted by autoantibodies against ADAMTS13 in patients with acquired idiopathic thrombotic thrombocytopenic purpura. Haematologica (2010) 1.27
Costs and cost effectiveness of a health care provider-directed intervention to promote colorectal cancer screening among Veterans. J Clin Oncol (2005) 1.27
Patient decision aids for prostate cancer treatment: a systematic review of the literature. CA Cancer J Clin (2009) 1.26
Palliative care. J Natl Compr Canc Netw (2012) 1.25
Evaluating the cost-effectiveness of cancer patient navigation programs: conceptual and practical issues. Cancer (2009) 1.24
Surgical outcomes of patients with gastric carcinoma: the importance of primary tumor location and microvessel invasion. Surgery (2003) 1.24
Clinical features and correlates of gemcitabine-associated lung injury: findings from the RADAR project. Cancer (2006) 1.19
Depressive symptoms and lower extremity functioning in men and women with peripheral arterial disease. J Gen Intern Med (2003) 1.16